For DME suppliers, financial cleanliness means defensible billing records, documented denial workflows, inventory reconciliation, and payer relationship audit trails that allow a buyer to verify your collection rate, payer mix, and margin assumptions at the letter of intent stage.
No cost. 15 minutes. No obligation.
For DME suppliers, financial cleanliness means defensible billing records, documented denial workflows, inventory reconciliation, and payer relationship audit trails that allow a buyer to verify your collection rate, payer mix, and margin assumptions at the letter of intent stage.
DME suppliers face intense scrutiny during diligence because reimbursement volatility, high denial rates, and Medicare audit exposure create valuation risk that buyers discount aggressively. When your chart of accounts mixes inventory, billing adjustments, and write-offs inconsistently, when denial root causes are not tracked by payer and HCPCS code, and when receivables aging does not reconcile to actual cash collected, buyers assume your stated EBITDA overstates true margin. A buyer who cannot verify your collection rate, confirm your payer contracts, or audit your inventory turnover will either walk or apply a steep discount. In the DME subsegments commanding 7x to 12x multiples, like respiratory and CPAP, financial opacity is the single fastest way to collapse into commodity pricing at 3x to 6x.
Chart of accounts redesign that segregates inventory by product category and turnover band, billing adjustments by denial reason code, and receivables by payer and aging bucket for monthly reporting.
Denial rate and collection rate dashboards by payer, HCPCS code, and product line, with root cause tagging and trend analysis that supports margin defense in diligence.
Inventory reconciliation process with monthly turnover calculation, obsolescence reserve methodology, and physical count variance tracking that buyers can audit.
Accounts receivable aging cleanup, including write-off policy implementation, bad debt reserve calculation, and payer-specific collection assumption documentation.
Payer contract and fee schedule library with reimbursement rate verification, renewal date tracking, and revenue concentration analysis by Medicare, Medicaid, and commercial mix.
Quality of earnings preparation package including normalized EBITDA bridge, working capital peg calculation, and cash flow reconciliation formatted for DME buyer diligence.
DME buyers, whether private equity platforms consolidating respiratory services or strategic acquirers seeking CPAP and hospital bed product lines, underwrite to reimbursement risk first and operational margin second. The spread between commodity DME at 3x to 6x and specialized subsegments at 7x to 12x is determined by verified payer relationships, defensible collection rates, and clean denial tracking that prove margin is not dependent on lax billing practices or unsustainable payer mix. Financial cleanliness is what allows a respiratory-focused supplier to command a double-digit multiple instead of being valued as a commodity distributor. Buyers will forensically audit your billing records, inventory turnover, and receivables aging; if those systems cannot produce verifiable KPIs, your valuation collapses regardless of revenue growth.
financial cleanliness and metrics for durable medical equipment suppliers is the intersection page. Read the full durable medical equipment suppliers advisory angle, the general financial cleanliness and metrics overview, or run the Value Creation Assessment to see where your practice stands.
Most DME suppliers count denials as a percentage of gross charges, which dramatically understates the margin impact because Medicare and Medicaid reimbursement is a fraction of charges. A buyer calculates denial rate from expected reimbursement and wants to see root cause by payer, HCPCS code, and denial reason. If you cannot show whether denials stem from documentation, authorization, or coverage issues, the buyer assumes your billing process is undisciplined and your margin is at risk from future audits or payer policy changes. Clean denial tracking with corrective action logs proves operational maturity and protects your multiple.
Inventory reconciliation means your balance sheet value matches physical counts, your turnover calculation by product category is auditable, and you have a documented obsolescence reserve for slow-moving items. Buyers will test your inventory during diligence because overstated inventory inflates working capital and creates a post-close adjustment. If you carry three years of wheelchair cushions or outdated CPAP masks on your books at full cost, the buyer will either demand a working capital credit or discount your purchase price. Monthly turnover reporting by category and a clear write-down policy prove you manage capital efficiently and eliminate valuation disputes.
Payer mix concentration creates reimbursement and regulatory risk that buyers discount unless you can document contract terms, renewal dates, and fee schedules for every material payer. If 70% of your revenue is Medicare and you cannot produce a current fee schedule or demonstrate diversification into commercial or managed Medicaid, the buyer sees single-payer dependency and applies a steeper discount. Financial cleanliness means your revenue by payer is reconciled monthly, contracts are centrally stored and date-tracked, and you can model the impact of a fee schedule cut or competitive bid loss. That documentation is what separates a strategic asset from a fragile vendor.
Receivables aging beyond 90 days in DME is often uncollectible because payer appeal windows have closed or patient responsibility is unrecoverable, yet many suppliers leave these balances on the books. Buyers will age your A/R by payer and demand write-off support for anything past 120 days because overstated receivables inflate enterprise value and create post-close working capital disputes. Financial cleanliness means you have a documented write-off policy, a bad debt reserve reconciled monthly, and aging reports that exclude balances you do not expect to collect. If your days in A/R are inflated by zombie receivables, your purchase price will be adjusted downward at close.
We build 13-week rolling cash forecasts that account for Medicare reimbursement lag, inventory replenishment cycles…
See the durable medical equipment suppliers angleProactive tax strategy for DME suppliers means aligning entity structure, owner compensation, and retirement vehicles…
See the durable medical equipment suppliers angleDME suppliers often overpay taxes by treating all owner earnings as W-2 salary, missing the after-tax advantage of…
See the durable medical equipment suppliers angleDME suppliers often reinvest in inventory or draw cash without a unified plan linking reimbursement volatility, payer…
See the durable medical equipment suppliers angleWe build a capital allocation framework that aligns debt, inventory investment, distribution timing, and working…
See the durable medical equipment suppliers angleDME suppliers pricing without job-level visibility lose margin to payer mix variation, billing denials, and delivery…
See the durable medical equipment suppliers angleExit readiness for a DME supplier means transforming billing accuracy, payer mix, inventory controls, and A/R hygiene…
See the durable medical equipment suppliers angleDME suppliers need senior financial leadership to manage payer mix, drive down denial rates, and enforce inventory…
See the durable medical equipment suppliers angleProduction per provider, collection rate, and payer mix. Dental practice value lives in the hygiene schedule a
See advisory angleProfitability by provider, location, and payer. Multi-provider groups live and die by payer mix and provider p
See advisory angleRepeat revenue, provider productivity, and margin per service line. Med spas are valued on whether the model r
See advisory angleThe Keystone Value Creation Assessment™ audits your last 12 to 36 months and gives you a written summary whether you engage us or not. If there is not a clear opportunity to create value, we will tell you directly.